Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2024 02:15 ET | Source: Sequana Medical NV

Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024

PRESS RELEASEREGULATED INFORMATION23 April 2024, 07:00 am CET Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024 Publication of Annual Report 2023...
April 23, 2024 02:00 ET | Source: Sequana Medical NV

Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024

PRESS RELEASEREGULATED INFORMATION23 April 2024, 07:00 am CET Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024 Publication of Annual Report 2023...
April 23, 2024 01:00 ET | Source: Sequana Medical NV

Sequana Medical announces Annual General Meeting of Shareholders on 25 May 2023

PRESS RELEASEREGULATED INFORMATION23 April 2024, 07:00 am CET Publication of Annual Report 2023 Ghent, Belgium – 23 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or...
April 11, 2024 12:00 ET | Source: Sequana Medical NV

Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION 11 April 2024, 06:00 pm CEST Ghent, Belgium – 11 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in...
April 08, 2024 12:30 ET | Source: Sequana Medical NV

Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION 8 April 2024, 06:30 pm CEST Ghent, Belgium – 8 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
April 03, 2024 12:00 ET | Source: Sequana Medical NV

Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION3 April 2024, 06:00 pm CEST Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
April 03, 2024 01:00 ET | Source: Sequana Medical NV

Strong data from DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure

Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana...
March 28, 2024 03:00 ET | Source: Sequana Medical NV

Sequana Medical announces 2023 Full Year Results and 2024 Outlook

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION28 March 2024, 08:00 a.m. CET alfapump® – PMA1 submitted to US FDA and accepted for substantive review, extensive feedback just received from...
March 26, 2024 02:00 ET | Source: Sequana Medical NV

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

PRESS RELEASEREGULATED INFORMATION26 March 2024, 07:00 a.m. CET Ghent, Belgium, 26 March 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the...
March 25, 2024 02:00 ET | Source: Sequana Medical NV

Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy

MOJAVE – US Phase 1/2a study of DSR 2.0 for treatment of heart failure Previously reported strong data maintained after three-months follow-up: Diuretic response remained nearly normalized, with a...